News
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...
Updated on: May 12, 2025 / 12:39 PM EDT / CBS News ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
T he obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular ...
Wegovy was the first to market from a newer generation of medicines known as GLP-1 agonists, originally developed for diabetes, that provide a new way to address record obesity rates.
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
Key Takeaways Wegovy is considered a safe and effective treatment for long-term weight loss. Possible problems with long-term use include pancreatitis, gallbladder disease, and kidney damage.
Wegovy’s starting dosage is a 0.25-milligram (mg) injection once per week. You’ll typically increase your dose every 4 weeks, up to 1.7 mg per week or 2.4 mg per week. Your doctor may adjust ...
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback